Surveillance report examines fungal infection trends in US during COVID-19 pandemic

This surveillance report examined trends in coccidioidomycosis, histoplasmosis, and blastomycosis cases across the United States from 2019 to 2021, coinciding with the COVID-19 pandemic. The report did not specify a comparator period or population sample size. No quantitative results, effect sizes, or statistical measures were reported for infection trends.

No safety or tolerability data were provided regarding fungal infections or any potential interactions with COVID-19. The analysis did not report funding sources or potential conflicts of interest.

Key limitations include the absence of reported results, making it impossible to assess the direction or magnitude of any trends. The observational nature of surveillance data precludes causal inference about pandemic effects. Without specific findings, this report has minimal direct practice relevance beyond highlighting continued surveillance of these endemic fungal diseases.